Preservation-reperfusion injury of hepatic allografts is thought to be
associated with Kupffer cell activation and TNF release from the tran
splanted organ. Confirmation that the allograft is the source of this
TNF in an in vivo model is difficult because of rapid equilibration of
this cytokine into all compartments. A novel experimental design was
devised to aid in accurate localization of the site of TNF release fol
lowing a orthotopic liver transplant (OLT). In the first group (anhepa
tic), livers were removed from rats and splanchnic and systemic venous
returns were then reestablished using a conduit of donor IVC and port
al vein with a portasystemic shunt. In the second group (asplanchnic),
the liver, stomach, pancreas, and intestine of the recipient were rem
oved and a donor liver was reimplanted using the recipient IVC as the
source of portal blood. The third (OLT-16) and fourth (OLT 8) groups u
nderwent standard OLT with preservation times of 16 and 8 hr in 4 degr
ees C Euro-Collins solution, respectively. TNF levels were significant
ly increased in the OLT-16 group compared with the OLT-8 group. There
were modest elevations of TNF in the anhepatic model, but the TNF in t
he asplanchnic model appreached baseline. Absence of TNF in the asplan
chnic group and a rise in TNF levels in the anhepatic group to that no
t significantly different from OLT-16 or OLT-8 suggest that a major so
urce of TNF following preservation reperfusion may be the intestine.